| Primary |
| Cerebral Vasoconstriction |
9.1% |
| Migraine |
9.1% |
| Subarachnoid Haemorrhage |
9.1% |
| Subarachnoid Hemorrhage |
9.1% |
| Cerebrovascular Spasm |
6.1% |
| Drug Use For Unknown Indication |
6.1% |
| Familial Hemiplegic Migraine |
6.1% |
| Headache |
6.1% |
| Vasospasm |
6.1% |
| Bipolar Disorder |
3.0% |
| Hyperlipidaemia |
3.0% |
| Hypertension |
3.0% |
| Menopausal Symptoms |
3.0% |
| Metastatic Renal Cell Carcinoma |
3.0% |
| Nausea |
3.0% |
| Neuralgia |
3.0% |
| Ruptured Cerebral Aneurysm |
3.0% |
| Sedation |
3.0% |
| Stroke |
3.0% |
| Vasospasm Cerebral |
3.0% |
|
| Incorrect Route Of Drug Administration |
21.1% |
| Renal Failure Acute |
10.5% |
| Vasogenic Cerebral Oedema |
10.5% |
| Cerebral Haemorrhage |
5.3% |
| Grand Mal Convulsion |
5.3% |
| Hyperkalaemia |
5.3% |
| Increased Tendency To Bruise |
5.3% |
| Monoparesis |
5.3% |
| Nodal Rhythm |
5.3% |
| Oxygen Saturation Decreased |
5.3% |
| Product Label Issue |
5.3% |
| Retinal Vein Occlusion |
5.3% |
| Urinary Retention |
5.3% |
| Wrong Technique In Drug Usage Process |
5.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
34.6% |
| Hypertension |
16.0% |
| Atrial Fibrillation |
11.1% |
| Product Used For Unknown Indication |
7.4% |
| Aneurysm Ruptured |
4.9% |
| Therapeutic Embolisation |
3.7% |
| Angiogram |
2.5% |
| Cerebrovascular Spasm |
2.5% |
| Migraine |
2.5% |
| Subarachnoid Haemorrhage |
2.5% |
| Cerebral Disorder |
1.2% |
| Cerebral Hypoperfusion |
1.2% |
| Gastric Ulcer |
1.2% |
| Haemodynamic Instability |
1.2% |
| Hyperlipidaemia |
1.2% |
| Parkinson's Disease |
1.2% |
| Ruptured Cerebral Aneurysm |
1.2% |
| Upper Respiratory Tract Infection |
1.2% |
| Vasospasm Cerebral |
1.2% |
| Vomiting |
1.2% |
|
| Hepatitis Toxic |
16.0% |
| Rash Pustular |
8.0% |
| Vasogenic Cerebral Oedema |
8.0% |
| Blood Pressure Decreased |
4.0% |
| Blood Pressure Increased |
4.0% |
| Caesarean Section |
4.0% |
| Cerebral Haemorrhage |
4.0% |
| Coma |
4.0% |
| Drug-induced Liver Injury |
4.0% |
| Fall |
4.0% |
| Gastritis Atrophic |
4.0% |
| Grand Mal Convulsion |
4.0% |
| Head Discomfort |
4.0% |
| Malaise |
4.0% |
| No Adverse Event |
4.0% |
| Premature Delivery |
4.0% |
| Skin Discolouration |
4.0% |
| Subarachnoid Haemorrhage |
4.0% |
| Toxic Skin Eruption |
4.0% |
| Transaminases Increased |
4.0% |
|
| Concomitant |
| Hypertension |
17.1% |
| Drug Use For Unknown Indication |
16.5% |
| Product Used For Unknown Indication |
10.8% |
| Rheumatoid Arthritis |
7.0% |
| Epilepsy |
6.4% |
| Cardiac Disorder |
4.0% |
| Prophylaxis |
3.8% |
| Convulsion |
3.6% |
| Type 2 Diabetes Mellitus |
3.6% |
| Depression |
3.2% |
| Osteoporosis |
3.2% |
| Dementia Alzheimer's Type |
2.8% |
| Pain |
2.8% |
| Reversible Ischaemic Neurological Deficit |
2.8% |
| Encephalitis |
2.6% |
| Diabetes Mellitus |
2.2% |
| Sleep Disorder |
2.0% |
| Cardiovascular Disorder |
1.8% |
| Cough |
1.8% |
| Hypothyroidism |
1.8% |
|
| Status Epilepticus |
10.1% |
| Lung Infiltration |
9.1% |
| Syncope |
8.1% |
| Vomiting |
7.1% |
| Stevens-johnson Syndrome |
6.1% |
| Subarachnoid Haemorrhage |
6.1% |
| Pneumonia |
5.1% |
| Thrombocytopenia |
5.1% |
| Wrong Technique In Drug Usage Process |
5.1% |
| Chest Pain |
4.0% |
| Neutropenia |
4.0% |
| Pulmonary Oedema |
4.0% |
| Sudden Death |
4.0% |
| Tremor |
4.0% |
| Blood Lactic Acid Increased |
3.0% |
| Idiopathic Thrombocytopenic Purpura |
3.0% |
| Pyrexia |
3.0% |
| Respiratory Distress |
3.0% |
| Sleep Disorder |
3.0% |
| Wrist Fracture |
3.0% |
|
| Interacting |
| Cerebrovascular Accident |
50.0% |
| Cystitis |
50.0% |
|
|
